SCHEMBL11589727

SCHEMBL11589727

Cc1ccc(C(=O)c2ccc3nc(N)sc3c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.64
▸ MAPT P10636 3/20 0.64
▸ LCK P06239 1/20 0.61
▸ ALDH1A1 P00352 4/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ LMNA P02545 4/20 0.54
▸ HSD17B10 Q99714 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ HTT P42858 2/20 0.52
▸ USP2 O75604 1/20 0.52
▸ GAA P10253 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ CYP2D6 P10635 3/20 0.51
▸ CYP2C9 P11712 3/20 0.50
▸ CYP3A4 P08684 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7759315 0.87 LMNA (0.67) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL11592918 0.85 GPR183 (0.56) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL3064646 0.85 PIK3CD (0.57) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL1638828 0.81 RAB9A (0.59) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL9722817 0.80 RAB9A (0.65) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL3113684 0.80 RAB9A (0.61) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL30563626 0.80 RAB9A (0.61) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL211024 0.80 RAB9A (0.66) RAB9AMAPTLCKALDH1A1NPC1
SCHEMBL7535 0.79 RAB9A (1.00) RAB9AMAPTALDH1A1NPC1LMNA
Bromide SCHEMBL10947640 0.78 RAB9A (0.64) RAB9AMAPTLCKALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4118384-A DIAZOTIZATION BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 — — US disclosed
Send feedback